TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Long-term Effects of Salmeterol/Fluticasone Propionate (Seretide tm) 50/500mcg BD, Salmeterol 50mcg BD and Fluticasone Propionate 500mcg BD, All Delivered Via the Diskus tm/Accuhaler tm Inhaler, on Mortality and Morbidity of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Over 3 Years of Treatment
Brief Summary: The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.


Options:
A: Intervention Type: DRUG; Name: Salmeterol 50mcg/ Fluticasone Propionate 500mcg; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Tiotropium; Assigned to Arm(s): N/A
C: Arm Label: Indacaterol 300 μg plus placebo to formoterol; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol, Drug: Placebo to formoterol | Arm Label: Indacaterol 600 μg plus placebo to formoterol; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol, Drug: Placebo to formoterol | Arm Label: Formoterol 12 μg plus placebo to indacaterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol, Drug: Placebo to indacaterol | Arm Label: Placebo to indacaterol plus placebo to formoterol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to indacaterol, Drug: Placebo to formoterol | Intervention Type: DRUG; Name: Indacaterol; Assigned to Arm(s): Indacaterol 300 μg plus placebo to formoterol, Indacaterol 600 μg plus placebo to formoterol | Intervention Type: DRUG; Name: Formoterol; Assigned to Arm(s): Formoterol 12 μg plus placebo to indacaterol | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Formoterol 12 μg plus placebo to indacaterol, Placebo to indacaterol plus placebo to formoterol | Intervention Type: DRUG; Name: Placebo to formoterol; Assigned to Arm(s): Indacaterol 300 μg plus placebo to formoterol, Indacaterol 600 μg plus placebo to formoterol, Placebo to indacaterol plus placebo to formoterol
D: Arm Label: Arformoterol 15 mcg twice daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: Arformoterol Tartrate Inhalation Solution, Drug: Placebo | Arm Label: Tiotropium 18 mcg once daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium, Drug: Placebo | Arm Label: Arformoterol /Tiotropium; Type: EXPERIMENTAL; Interventions: Drug: Arformoterol and Tiotropium | Intervention Type: DRUG; Name: Arformoterol Tartrate Inhalation Solution; Assigned to Arm(s): Arformoterol 15 mcg twice daily | Intervention Type: DRUG; Name: Tiotropium; Assigned to Arm(s): Tiotropium 18 mcg once daily | Intervention Type: DRUG; Name: Arformoterol and Tiotropium; Assigned to Arm(s): Arformoterol /Tiotropium | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arformoterol 15 mcg twice daily, Tiotropium 18 mcg once daily

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Long-term Effects of Salmeterol/Fluticasone Propionate (Seretide tm) 50/500mcg BD, Salmeterol 50mcg BD and Fluticasone Propionate 500mcg BD, All Delivered Via the Diskus tm/Accuhaler tm Inhaler, on Mortality and Morbidity of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Over 3 Years of Treatment
Brief Summary: The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.


Options:
A: Intervention Type: DRUG; Name: Tiotropium bromide 18mcg; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Fluticasone propionate/ salmeterol combination 50/500mcg; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Salmeterol 50mcg/ Fluticasone Propionate 500mcg; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Budesonide/formoterol pMDI; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Budesonide pMDI; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Formoterol Turbuhaler; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: fluticasone 500 mcg; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: fluticasone 500 mcg + salmeterol 50 mcg; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cellular Transplantation of Autologous Bone Marrow-Derived Stem Cells Following Myocardial Infarction
Brief Summary: The goal of this study is to determine the safety of giving a patient's own bone marrow-derived stem cells delivered with a catheter (tube) into the coronary arteries (blood vessels of the heart). Stem cells are simple cells produced by the bone marrow that can develop into many types of cells. It is possible that these cells will decrease the size of damage caused to the heart from a heart attack and increase the pumping efficiency of the heart; which can be decreased due to a heart attack. The stem cells will be taken from bone marrow and then given back into the heart vessels.


Options:
A: Arm Label: Intracoronary; Type: EXPERIMENTAL; Interventions: Other: Bone marrow derived progenitor cells or placebo infusion | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo infusion | Intervention Type: OTHER; Name: Bone marrow derived progenitor cells or placebo infusion; Assigned to Arm(s): Intracoronary | Intervention Type: OTHER; Name: Placebo infusion; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: Adult stem cells | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Adult stem cells; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: Cell therapy; Type: EXPERIMENTAL; Interventions: Drug: Autologous, Unfractionated Bone Marrow Mononuclear Cells | Intervention Type: DRUG; Name: Autologous, Unfractionated Bone Marrow Mononuclear Cells; Assigned to Arm(s): Cell therapy
D: Intervention Type: DRUG; Name: G-CSF with/without darbepoetin, peripheral blood stem cell infusion; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
C: Intervention Type: DEVICE; Name: Total Disc Prosthesis; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Multidisciplinary rehabilitation program; Assigned to Arm(s): N/A
D: Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard physical therapy | Arm Label: Graded exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Graded exercise | Arm Label: Graded exposure; Type: EXPERIMENTAL; Interventions: Other: Graded exposure | Intervention Type: BEHAVIORAL; Name: Standard physical therapy; Assigned to Arm(s): Standard | Intervention Type: BEHAVIORAL; Name: Graded exercise; Assigned to Arm(s): Graded exercise | Intervention Type: OTHER; Name: Graded exposure; Assigned to Arm(s): Graded exposure

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Arm Label: Aerobic and flexibility exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic | Arm Label: Strength, aerobic, and flexibility; Type: EXPERIMENTAL; Interventions: Behavioral: Strength training | Arm Label: Fibromyalgia Self-Help Course; Type: EXPERIMENTAL; Interventions: Behavioral: FSHC | Arm Label: a Combination of ST and FSHC; Type: EXPERIMENTAL; Interventions: Behavioral: Combination | Intervention Type: BEHAVIORAL; Name: Aerobic; Assigned to Arm(s): Aerobic and flexibility exercise | Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): Strength, aerobic, and flexibility | Intervention Type: BEHAVIORAL; Name: Combination; Assigned to Arm(s): a Combination of ST and FSHC | Intervention Type: BEHAVIORAL; Name: FSHC; Assigned to Arm(s): Fibromyalgia Self-Help Course
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
C: Intervention Type: BEHAVIORAL; Name: walking program, resistance muscular exercise; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
B: Arm Label: Tai Chi Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi Intervention | Arm Label: Control Intervention; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control Intervention | Intervention Type: BEHAVIORAL; Name: Tai Chi Intervention; Assigned to Arm(s): Tai Chi Intervention | Intervention Type: BEHAVIORAL; Name: Control Intervention; Assigned to Arm(s): Control Intervention
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
D: Arm Label: A. High intensive exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Arm Label: B. Low-intensive exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active comparator: low intensive exercise | Intervention Type: BEHAVIORAL; Name: Physical exercise; Assigned to Arm(s): A. High intensive exercise | Intervention Type: BEHAVIORAL; Name: Active comparator: low intensive exercise; Assigned to Arm(s): B. Low-intensive exercise

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: desipramine hydrochloride | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: cognitive behavioral therapy | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Drug: desipramine hydrochloride, Behavioral: cognitive behavioral therapy | Arm Label: Arm 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: benztropine mesylate 0.125 mg daily | Intervention Type: BEHAVIORAL; Name: cognitive behavioral therapy; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: desipramine hydrochloride; Assigned to Arm(s): Arm 3 | Intervention Type: BEHAVIORAL; Name: cognitive behavioral therapy; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: benztropine mesylate 0.125 mg daily; Assigned to Arm(s): Arm 4 | Intervention Type: DRUG; Name: desipramine hydrochloride; Assigned to Arm(s): Arm 1
B: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
C: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Behavioral: ACT | Arm Label: Physical activity; Type: EXPERIMENTAL; Interventions: Other: Physical activity | Arm Label: Experience based discussion group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ACT; Assigned to Arm(s): ACT | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Physical activity
D: Arm Label: CBT-I; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I) | Arm Label: CBT-P; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for Pain (CBT-P) | Arm Label: Waitlist Control (WLC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Insomnia (CBT-I); Assigned to Arm(s): CBT-I | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Pain (CBT-P); Assigned to Arm(s): CBT-P

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
B: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Attention Control Counseling | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Attention Control Counseling; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): 2
C: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Arm Label: A. High intensive exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Arm Label: B. Low-intensive exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active comparator: low intensive exercise | Intervention Type: BEHAVIORAL; Name: Physical exercise; Assigned to Arm(s): A. High intensive exercise | Intervention Type: BEHAVIORAL; Name: Active comparator: low intensive exercise; Assigned to Arm(s): B. Low-intensive exercise
B: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
C: Arm Label: Aerobic and flexibility exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic | Arm Label: Strength, aerobic, and flexibility; Type: EXPERIMENTAL; Interventions: Behavioral: Strength training | Arm Label: Fibromyalgia Self-Help Course; Type: EXPERIMENTAL; Interventions: Behavioral: FSHC | Arm Label: a Combination of ST and FSHC; Type: EXPERIMENTAL; Interventions: Behavioral: Combination | Intervention Type: BEHAVIORAL; Name: Aerobic; Assigned to Arm(s): Aerobic and flexibility exercise | Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): Strength, aerobic, and flexibility | Intervention Type: BEHAVIORAL; Name: Combination; Assigned to Arm(s): a Combination of ST and FSHC | Intervention Type: BEHAVIORAL; Name: FSHC; Assigned to Arm(s): Fibromyalgia Self-Help Course
D: Arm Label: Dance Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dance | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: Other: Control Group | Intervention Type: BEHAVIORAL; Name: Dance; Assigned to Arm(s): Dance Group | Intervention Type: OTHER; Name: Control Group; Assigned to Arm(s): Control Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Arm Label: Physcial exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physcial activity | Arm Label: Relaxation exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physcial activity | Intervention Type: BEHAVIORAL; Name: Physcial activity; Assigned to Arm(s): Physcial exercise, Relaxation exercise
B: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
C: Arm Label: A. High intensive exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Arm Label: B. Low-intensive exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active comparator: low intensive exercise | Intervention Type: BEHAVIORAL; Name: Physical exercise; Assigned to Arm(s): A. High intensive exercise | Intervention Type: BEHAVIORAL; Name: Active comparator: low intensive exercise; Assigned to Arm(s): B. Low-intensive exercise
D: Arm Label: strengthening exercise; Type: EXPERIMENTAL; Interventions: Other: strengthening exercise | Arm Label: Flexibility exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: flexibility exercise | Intervention Type: OTHER; Name: strengthening exercise; Assigned to Arm(s): strengthening exercise | Intervention Type: OTHER; Name: flexibility exercise; Assigned to Arm(s): Flexibility exercise

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Brief Summary: The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk. For this purpose, fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options. It is expected that this approach will result in increased magnitude and maintenance of effects.


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Attention Control Counseling | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Attention Control Counseling; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
C: Arm Label: Workshop; Type: EXPERIMENTAL; Interventions: Behavioral: Affective Self-Awareness workshop | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Affective Self-Awareness workshop; Assigned to Arm(s): Workshop
D: Arm Label: CTB Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): CTB Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter Prospective Study to Assess the Impact of Physician's Reinforcement on the Subject's Compliance and Persistence on Treatment Using Feedback on Bone Markers in Previously Undiagnosed Postmenopausal Osteoporotic Women Treated With Risedronate.
Brief Summary: The primary objective of this study is to assess the impact of physician's reinforcement using bone marker data on the subject's compliance (at least 50% drug taken) and persistence on treatment after one year in postmenopausal osteoporotic women.


Options:
A: Intervention Type: DRUG; Name: risedronate; Assigned to Arm(s): N/A
B: Arm Label: Teriparatide; Type: EXPERIMENTAL; Interventions: Drug: Teriparatide, Drug: Placebo, Drug: Calcium, Drug: Vitamin D | Arm Label: Risedronate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Risedronate, Drug: Placebo, Drug: Calcium, Drug: Vitamin D | Intervention Type: DRUG; Name: Teriparatide; Assigned to Arm(s): Teriparatide | Intervention Type: DRUG; Name: Risedronate; Assigned to Arm(s): Risedronate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Risedronate, Teriparatide | Intervention Type: DRUG; Name: Calcium; Assigned to Arm(s): Risedronate, Teriparatide | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): Risedronate, Teriparatide
C: Arm Label: Genistein vs. Risedronate; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Genistein vs Risedronate | Arm Label: Genistein dose and source; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Genistein vs Risedronate | Intervention Type: DIETARY_SUPPLEMENT; Name: Genistein vs Risedronate; Assigned to Arm(s): Genistein dose and source, Genistein vs. Risedronate
D: Arm Label: 5 mg Before Breakfast; Type: ACTIVE_COMPARATOR; Interventions: Drug: risedronate | Arm Label: 35 mg After Breakfast; Type: EXPERIMENTAL; Interventions: Drug: risedronate | Arm Label: 35 mg Before Breakfast; Type: EXPERIMENTAL; Interventions: Drug: risedronate | Intervention Type: DRUG; Name: risedronate; Assigned to Arm(s): 5 mg Before Breakfast | Intervention Type: DRUG; Name: risedronate; Assigned to Arm(s): 35 mg After Breakfast | Intervention Type: DRUG; Name: risedronate; Assigned to Arm(s): 35 mg Before Breakfast

Answer: A